BROADWOOD PARTNERS, L.P.
BROADWOOD PARTNERS, L.P.'s open-market purchases and sales year by year since 2006, and every transaction reported to the SEC on Form 4: date, shares, price…
Insider buying and selling since 2007
BROADWOOD PARTNERS, L.P. bought shares on the open market in 15 different years since 2007 across 3 companies. Sales in 2 of the 20 years since 2007.
BROADWOOD PARTNERS, L.P. reported 202 open-market purchases and 14 sales since 2007; purchases in 15 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | 7×7 trades | — |
| 2025 | 37×37 trades | — |
| 2024 | 18×18 trades | — |
| 2023 | 2×2 trades | — |
| 2022 | 8×8 trades | — |
| 2021 | — | 12×12 trades |
| 2019 | 4×4 trades | — |
| 2017 | 4×4 trades | — |
| 2016 | 26×26 trades | — |
| 2015 | 10×10 trades | — |
| 2014 | 7×7 trades | — |
| 2013 | 2×2 trades | — |
| 2012 | 4×4 trades | — |
| 2011 | 2×2 trades | — |
| 2008 | 20×20 trades | — |
| 2007 | 51×51 trades | 2×2 trades |
Insider at 3 companies
- Insight Molecular Diagnostics IMDX2019–2026 · 20 purchases, 0 sales
- STAAR Surgical Company STAA2007–2025 · 162 purchases, 12 sales
- Lineage Cell Therapeutics LCTX2007–2025 · 20 purchases, 2 sales
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. The amounts, the people and every filing are in OQRO Pro.
Trades disclosed
Latest trade
Largest trade
Companies
Every disclosed trade
Every trade this person has disclosed
Newest first, each one linked to the filing it came from.
Already a member? Sign in
What this page holds
- Every disclosed trade, newest first
- How purchases did after they were reported
- Companies and committees involved
- A link to every official filing
What OQRO is
OQRO reads the public record for US-listed companies — insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings, and federal contract awards — and puts each one in plain words next to the filing it came from. It describes what was disclosed. It does not give investment advice or tell you what to buy.
Want to see real filings before you pay? The home page shows live ones, free, with the link to each source document.
Questions about BROADWOOD PARTNERS, L.P.'s trades
Has BROADWOOD PARTNERS, L.P. bought shares on the open market?
BROADWOOD PARTNERS, L.P. bought shares on the open market in 15 different years since 2007 across 3 companies. Sales in 2 of the 20 years since 2007.
When did BROADWOOD PARTNERS, L.P. last buy or sell shares?
In SEC filings since 2007: the latest open-market purchase is from 2026; the latest open-market sale is from 2021.
Which companies has BROADWOOD PARTNERS, L.P. traded as an insider?
3 companies: Insight Molecular Diagnostics (IMDX, 2019–2026), STAAR Surgical Company (STAA, 2007–2025), Lineage Cell Therapeutics (LCTX, 2007–2025).